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All adult tissues studied to date, with the exception
of tumor (2, 3, 5, 6, 7, 13), corpus luteum (l0),
epidermis (25), and lymphatic tissue (2, 8, 23), are
incapable of stimulating vasoproliferation . There
is, however, considerable indirect evidence sug-
gesting that adult retina, under certain conditions,
is capable of stimulating vasoproliferation . This
evidence stems from observations of several ocular
diseases in which neovascularization closely par-
allels local or remote retinal nonperfusion (1, 14,
16, 21, 22) . The treatment of the abnormal retinal
tissue by laser or xenon arc photocoagulation re-
sults in the regression of these new vessels (15, 17,
19) . In spite of this indirect evidence, a retina-
derived substance capable of promoting vasopro-
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ABSTRACT
Vasoproliferative activity has been demonstrated in extracts of retinas from
human, bovine, and feline sources . These retinal extracts are capable ofstimulating
(a) proliferation and thymidine uptake of bovine vascular endothelial cells in
culture and (b) neovascularization on the chick chorioallantoic membrane . Ex-
tracts of skeletal muscle, cardiac muscle, and liver lack similar stimulatory activity .
The activity is nondialyzable, stable at 56°C, and inactivated at 100°C . Retinal
extracts stimulate the proliferation of corneal fibroblasts but have no effect on the
proliferation of vascular smooth muscle cells .
Indirect evidence suggests the liberation of a vasoproliferative factor from retina
in several ocular disorders . The data in this report represent the first direct
demonstration of vasoproliferative activity from mammalian retina.
liferation has yet to be demonstrated . The follow-
ing experiments provide the first direct proof that
mammalian retina can liberate a substance (or
substances) with potent vasoproliferative activity .
MATERIALS AND METHODS
Tissue Extracts
RETINA : Eyes from recently slaughtered adult cows were
obtained from a local abattoir. Retinas were removed from 14
eyes and suspended in 14 ml of balanced salt solution (BSS: 8 g/
liter NaCl, 0 .2 g/liter KCI, 0 .2 g/liter KH 2 PO,-H_O, 1 .15 g/liter
Na_HPO,.7H_O, 0 .2 g/liter glucose, 0 .01 g/liter phenol red) at
room temperature and pH 7 .2 for 2 .5-3 h . The suspension was
centrifuged at 850 g for 5 min at room temperature. The super-
nate was then decanted and filter-sterilized (0 .2 lrm, Millipore
Corp ., Bedford, Mass .) . This retinal extract was used immediately
or stored at -20°C . Thirty separate batches of bovine retinal
extract were prepared and studied as described .
Human retinas from eye-bank eyes without known ocular
disease were suspended in 0 .5 ml of BSS per retina. The resulting
extract was treated in the same manner as the bovine retinal
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extract . These human eyes were obtained 2-4 d after death from
donors ranging in age from 41 to 88 yr, with an average of 59 yr .
Ten adult cats were anesthetized intramuscularly with 25 mg/
kg of ketamine hydrochloride (Ketaset, Bristol Laboratories Div.,
Bristol-Myers Co ., Syracuse, N.Y,) . One eye of each cat was
enucleated, and the central retinal artery was cannulated with a
small polyethylene tube (Intramedic, PE 50, Clay-Adams Div.
Becton, Dickinson & Co., Parsippany, N.J .) . The retinal circu-
lation was then perfused for 5 min with BSS (without phenol
red) at a pressure of 100 mm Hg. Each retina was examined with
an operating microscope at 40 x to ensure that all vessels were
cleared ofblood. The retina was then removed and treated in the
manner described for human retinas . The other eye of each cat
was enucleated, and the retina was removed but was not perfused
and treated in the same manner as the BSS-perfused retinas .
Immediately after enucleation, all cats were sacrificed by intra-
venous injection of sodium pentobarbital in alcohol-propylene
glycol base (Somlethal, Medtech, Inc., Elwood, Kans .) .
OTHER TIs sUEs :
	
Extracts of bovine skeletal muscle, cardiac
muscle, and liver were prepared in the manner described for
bovine retinas. The ratio of tissue weight to BSS volume was
made equal to that used for bovine retinal extract .
Cell Proliferation Studies
REAGENTS : All reagents used were of tissue-culture grade.
Minimal essential medium (MEM) and Medium-199 (M199)
were purchased from Grand Island Biological Co ., Grand Island,
N.Y ., collagenase(Type I) from Worthington BiochemicalCorp .,
Freehold, N.J., and trypsin (Type III, bovine pancreas) from
Sigma Chemical Co ., St . Louis, Mo . Fetal bovine serum (FBS)
was obtained from Sterile Systems Inc., Logan, Utah, and filter-
sterilized before use. Tritiated thymidine (1 mCi/ml; 6.7 Ci/mM)
was purchased from New England Nuclear, Boston, Mass. The
scintillation fluid used consistedof0.094 g of 2,5-diphenyloxazole
(PPO), 4.15 gof 1,4-bis(2-[4-methyl-5-phenyl-oxazolyll)-benzene
(dimethyl POPOP), 250 ml of Triton X-100, and 500 ml of
toluene.
CELL CULTURES : Endothelial cells were enzymatically re-
moved from fetal bovine aortas and cultured as previously re-
ported (5) . Cells were grown in MEMsupplemented with gluta-
mine (0 .292 mg/ml), sodium bicarbonate (2.2 mg/ml), penicillin
(200 U/ml), streptomycin (200 wg/ml) and 10% FBS at 37°C in
5%n COz with 85% relative humidity . These cells formed a char-
acteristic mosaic of nonoverlapping, polygonal cells. The pres-
ence of Weibel-Palade bodies (20), which are associated with
endothelial cells (24) and positive staining with anti-Factor VIII
antibodies (l2) showed them to be endothelial cells .
Smooth muscle cells were grown from explants of the medial
layer of fetal bovine aorta and maintained in MEM with 10%
FBS. Elaboration of an insoluble extracellular material and the
peculiar pattern of cell growth as observed by phase-contrast
microscopy (criteria suggested by Gimbrone and Cotran [91)
indicated their smooth-muscle-cell nature.
Corneal fibroblasts were grown from explants of corneal tissue
according to the procedure of BenEzra (4) and were also main-
tained in MEM with 10% FBS.
TRITIATED THYMIDINE UPTAKE BY ENDOTHELIAL
CELLS: Endothelial cells (passages 6-27) were plated in 24-well
plates (Falcon Lobware, Div. of Becton . Dickinson & Co ., Ox-
nard, Calif.) in MEM with 10% FBS at a density of 20,000-
25,000 cells/well (2 .1-cm') for use that day or at 10,000-15,000
cells/well for use the following day. At this density, the cells
remained subconfluent for the entire experiment . The maximal
final cell number was -8 .0 x 10" cells/well, about one-third of
the cell number at confluence. After the cells attached, each well
was rinsed with 1 ml of BSS before the addition of l ml ofM199
with 1% FBS. t-80-lal volumes o£each retinal extract were added
to triplicate wells, and control wells received equivalent volumes
of BSS. The final dilution of retinal extract in each well was
recorded . 42-48 h later, the cells were incubated for 1 h with 1
ml of tritiated thymidine (0 .625 pCi/ml) in serum-free MEM.
The incorporation was terminated by rinsing with cold BSS. The
cells werethen fixed by immersion for 3 min at room temperature
in a 1 :1 solution of BSS/ethanol-acetic acid fixative, for 20 min
in ethanol-acetic acid fixative (three parts 70% ethanol to one
part acetic acid), and for 10 min in 0.3 N perchloric acid followed
by a thorough rinse with distilled water. The fixed cells were
incubated for 20 min in 200 111 of0.25 N NaOH before an equal
volume of distilled water was added. The hydrolysate was then
transferred to a glass scintillation vial with 3 ml of scintillation
fluid, and the sample was counted for I min (20).
CELL COUNTING : Endothelial cells, smooth muscle cells,
and corneal fibroblasts were plated in 24-well plates as described
above . I-80-Al volumes of the extract to be tested were added to
triplicate wells, and the final dilutions were recorded . 42-48 h
later, the cells in each well were rinsed with BSS, trypsinized (0.3
ml of 0.1% trypsin-0.05% EDTA), and the enzyme activity was
quenched by the addition of0.7 ml o£ MEMwith 10% FBS. The
entire 1.0 ml was then transferred to a plastic cuvette containing
9 ml of Isoton II, a balanced electrolyte solution (Coulter Diag-
nostics Inc., Hialeah, Fla.), and counted with a Coulter Counter
Model 2-B (Coulter Electronics Inc., Hialeah, Fla.) .
Chick Chorioallantoic Membrane (CAM)
Assay
Extracts of retina, bovine skeletal muscle, cardiac muscle, and
liver were lyophilized and incorporated into I-mm'' Elvax (an
ethylene-vinyl acetate copolymer) pellets as described by Langer
and Folkman (l8) . Each pellet contained 20-25 pl of crude
extract. These pellets were assayed for their vasoproliferative
activity on the CAM according to the technique described by
Folkman et al . (3, 7, 13) with some modifications . Fertilized
White Leghorn chicken eggs were used . When the eggs were 6 d
old, a small hole in the egg shell overlying the air sac was made
with a 20-gauge needle . A 1-cm' window was then made in the
shell overlying the CAM, and the CAMwas allowed to fall away
from the window (I1) . The window was covered by clear tape,
and the eggs were incubated at 38 °C with 60% relative humidity .
2 d later, a 30-gauge hypodermic needle was used to puncture
the membrane at the intended site of implantation. One of the
Elvax pellets was placed over this puncture site, and the mem-
brane was covered with a plastic coverslip (Thermanox, 15-mm
round, Lux Scientific Corp., Newbury Park, Calif.) to limit pellet
migration.' The CAMwere examined daily at 16 x magnification
and scored 4 d after implantation . The number of new vascular
loops that had grown toward the pellet were counted . The
membrane vasculature was then injected with India ink, excised,
fixed in formalin, and photographed .
' Folkman, J., Children's Hospital, Boston, Mass . As
reported at the Juvenile Diabetes Foundation Workshop
on Diabetic Retinopathy (Boston, Sept. 14-16, 1978).
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RESULTS
Effects of Tissue Extracts on Vascular
Endothelial Cells in Culture
The increases in cell number and tritiated thy-
midine uptake resulting from the addition of bo-
vine retinal extract to cultured vascular endothelial
cells are shown in Figs . 1 and 2. Increasing the
concentration of retinal extract produces an in-
crease in both cell number and tritiated thymidine
uptake from control levels to a plateau ofmaximal
stimulation . Comparison of Figs . 1 and 2 shows
that the stimulation of tritiated thymidine uptake
correlates well with the increase in cell number
resulting from the addition ofretinal extract . Mello
(20) has demonstrated a similar correlation in
response to tumor homogenates. Human retinal
extracts, in an analogous study, have a comparable
effect on tritiated thymidine uptake (Fig . 3) . Com-
parison of Figs. 2 and 3 reveals that the effect of
human retinal extract on thymidine incorporation
is less than the effect of bovine retinal extract . As
mentioned earlier, bovine eyes were obtained
within 2-3 h after death of the animal, whereas
human eyes were obtained 2-1d after death. This
prolonged time interval before removal of retinas
from the human eye may have resulted in the loss
or destruction of some of the angiogenic activity .
We have found angiogenic activity in the vitreous
300
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FIGURE 1
	
Effect of bovine retinal extract on the pro-
liferation of bovine vascular endothelial cells in culture .
All wells (2 .1 -cm2) contained 20,000-25,000 cells in M199
with 1 .0% FBS . 1-80-A1 volumes of bovine retinal extract
were added to triplicate wells . Control wells received
equivalent volumes of BSS . 42-48 h later, the cells were
trypsinized and counted. Control wells contained 40,000
± 2,000 cells . Each point represents the mean oftriplicate
wells . Standard deviation is represented by a vertical bar.
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FIGURE 2 Effect of bovine retinal extract on tritiated
thymidine uptake by bovine vascular endothelial cells in
culture . All wells (2 .1-cm2) contained 20,000-25,000 cells
in M199 with 1.0% FBS . 1-80-tL1 volumes of bovine
retinal extract were added to triplicate wells. Control
wells received equivalent volumes ofBSS . 42-48 h later,
the cells were incubated for 1 h with tritiated thymidine.
The medium was removed, and the cells were washed,
fixed, and lysed with 0.25 N NaOH . The hydrolysate
was then counted. Control wells contained 13,500 ±
1,000 cpm. Each point represents the mean of triplicate
wells. Standard deviation is represented by a vertical bar.
of these human eyes, but we were unable to dem-
onstrate such activity in bovine vitreous (data not
shown) . This finding suggests that some of the
angiogenic activity of these human retinas may
have been lost by diffusion into the vitreous during
the prolonged interval before removal of the ret-
ina. In summary, bovine and human retinal ex-
tracts stimulate the proliferation and thymidine
uptake of vascular endothelial cells in culture . This
response is dose dependent.
Because the addition of serum to cultured vas-
cular endothelial cells is known to stimulate triti-
ated thymidine incorporation (5, 20), it was nec-
essary to demonstrate that the effect of retinal
extracts was not the result of the small amount of
serum retained in the retinal vasculature . To ac-
complish this, an extract from feline retinas whose
vasculature was cleared ofblood by perfusion with
BSS was compared with an extract from untreated
feline retinas . Equal dilutions of these two extracts
stimulated equal levels of tritiated thymidine up-
take by bovine vascular endothelial cells . There-
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fore, the effect of retinal extract on endothelial
cells is independent of any serum growth factors
that may remain in the retinal vasculature .
Fig. 4 illustrates the effects of extracts of bovine
cardiac muscle, skeletal muscle, and liver on vas-
cular endothelial cell number . Addition of the
same range of dilutions used for retinal extracts
failed to stimulate the proliferation of endothelial
cells. In fact, in contrast to retina, high concentra-
tions ofliver and cardiac muscle extracts appeared
to have deleterious effects on cultured endothelial
cells .
Effect of Tissue Extracts on the CAM
The vasoproliferative activities of various tissue
extracts on the CAMare shown in Table I. 50% of
the pellets containing retinal extract induced
strong vasoproliferation, and 25% elicited a weak
response . In comparison, none of the pellets con-
taining extracts of other tissues induced strong
vasoproliferation, and only 13% were capable of
inducing a weak neovascular response . Represent-
ative photographs of the CAM neovascular re-
sponse to tissue extracts in Elvax pellets are shown
in Fig. 5 . To investigate the statistical significance
of the retinal extract-induced vasoproliferation,
50 20 10
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FIGURE 3
	
Effect of human retinal extract on tritiated
thymidine uptake by bovine vascular endothelial cells in
culture. All wells (2 . 1-cm) contained 20,000-25,000 cells
in M199 with 1 .0% FBS. 1-80-p1 volumes of human
retinal extract were added to triplicate wells. Control
wells received equivalent volumes of BSS. 42-48 h later,
the cells were incubated for l h with tritiated thymidine.
The medium was removed, and the cells were washed,
fixed, and lysed with 0.25 N NaOH . The hydrolysate
was then counted. Control wells contained 13,500 ±
1,000 cpm. Each point represents the mean of triplicate
wells . Standard deviation is represented by a vertical bar.
Fischer's exact test for 2 x 2 tables was used . The
test was performed both with the weak responses
grouped with the strong responses and with the
weak responses grouped with negative responses.
In both cases P< 0.001, indicating that extracts of
adult retina are capable of inducing highly signif-
icant vasoproliferation in vivo . In comparison,
extracts of the other adult tissues tested did not
induce significant vasoproliferation .
Effect of Bovine Retinal Extract on Smooth
Muscle Cells and Corneal Fibroblasts
The same range of dilutions of bovine retinal
extract that stimulated vascular endothelial cells
EXTRACT DILUTION
FIGURE 4 Effect of extracts of bovine skeletal muscle
(0), cardiac muscle (W, and liver (A) on the proliferation
of bovine vascular endothelial cells in culture . All wells
(2 .1-cm2 ) contained 20,000-25,000 cells in M199 with
1 .0% FBS. 1-80-pl volumes of each extract were added
to triplicate wells. Control wells received equivalent vol-
umes of BSS. 42-48 h later, the cells were trypsinized
and counted. Control wells contained 40,000 ± 2,000
cells. Each point represents the mean of triplicate wells .
Standard deviation is represented by a vertical bar.
TAFLE I
Vasoproliferative Response on the Chorioallantoic
Membrane
* 4 or more new vessel loops directed toward the test
pellet .
$ 1-3 new vessel loops directed toward the test pellet.
§ No new vessel loops seen .
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FIGURE 5
	
CAM vasoproliferative response . (a) Negative vasoproliferative response of CAM to extract
of control tissue (skeletal muscle) in Elvax pellet . No new vessel loops are present . (b) Strong vasoproli-
ferative response of CAM to retinal extract in Elvax pellet . Arrows show new vessel loops growing onto
the test pellet . Formalin-fixed, India-ink injections . x 40 .
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did not stimulate the proliferation of vascular
smooth muscle cells . However, a significant in-
crease in cell number resulted from the addition
of retinal extract to cultures of corneal fibroblasts
(Fig. 6) .
Physical Characteristics
Several physical properties of the active sub-
stance(s) contained in bovine retinal extracts were
studied. The capacity of retinal extracts to stimu-
late endothelial cell proliferation and CAM neo-
vascularization is unaffected by treatment at 56°C
for 30 min. Heating of retinal extracts to 100°C
for 2 min resulted, however, in a loss of this
stimulatory activity . This activity is also nondi-
alyzable (molecular weight cut-off of 10,000-
12,000) and stable to lyophilization .
DISCUSSION
We have demonstrated vasoproliferative activity
liberated by retina from several mammalian spe-
cies . These retinal extracts induce a plateauing,
dose-dependent stimulation of bovine aortic en-
dothelial cells in culture . Studies using retinas
cleared of blood prove that this stimulatory activ-
ity is not the result of serum growth factors that
may remain in the retinal vasculature . The in vivo
vasoproliferative activity of retinal extract is dem-
onstrated by its effect on the CAM.
The vasoproliferative activity of adult retina
contrasts with the observation that most other
adult tissues are incapable of stimulating neovas-
cularization . Fenselau and Mello (5) found that
homogenates of liver and kidney from the adult
cow and rat failed to stimulate proliferation of
cultured bovine vascular endothelial cells . Aus-
prunk et al . (3) found that adult rat skeletal muscle,
heart, liver, and kidney were incapable of inducing
neovascularization on the CAM. In our study,
extracts of bovine skeletal muscle, cardiac muscle,
and liver were incapable of stimulating prolifera-
tion ofcultured vascular endothelial cells or CAM
neovascularization . The question that still remains
is whether the tissues cited above can liberate a
vasoproliferative substance under conditions so far
not studied. The purification and characterization
of a retinal vasoproliferative substance and the
study of its production and release may aid in
addressing this question .
The ability of a retina-derived substance to in-
duce neovascularization correlates with the impor-
tant role of vasoproliferation in several ocular
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FtcURE 6 Effect of bovine retinal extract on bovine
vascular smooth muscle cells (") and corneal fibroblasts
(O) in culture . All wells (2 .1-cm2) contained 20,000-
25,000 cells in M199 with 1.0% FBS. 1-80-p1 volumes of
bovine retinal extract were added to triplicate wells.
Control wells received equivalent volumes of BSS. 42-
48 h later, the cells were trypsinized and counted. Each
point represents the mean of triplicate wells . Standard
deviation is represented by a vertical bar.
diseases and with the clinical evidence suggesting
the liberation of a vasoproliferative factor from
retina in these disorders. On the basis of clinical
and laboratory research, Patz (21, 22) and Ashton
et al . (1) independently demonstrated that areas of
peripheral retinal capillary closure precede local
retinal neovascularization in retrolental fibropla-
sia . Studies of patients with venous obstructive
disease reveal a direct correlation between retinal
capillary closure and neovascularization of the
optic nerve and iris (14, 16). Clinical studies show
that the destruction of retinal elements by laser or
xenon arc photocoagulative treatment results in
the regression of untreated disk, retinal, and iris
neovascularization (15, 17, 19). These studies sug-
gest that, under certain conditions, retina can lib-
erate a substance (or substances) capable of induc-
ing intraocular neovascularization . Despite the
considerable indirect evidence previously reported
for the existence of such a substance, it has never
been directly demonstrated .
The capacity of retinal extract to stimulate cell
proliferation appears to have some target-cell spec-
ificity because it acts as a potent stimulator of
vascular endothelial cell and corneal fibroblast
proliferation and has no effect on the proliferation
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of vascular smooth muscle cells . The ability of
retinal extracts to stimulate fibroblast proliferation
may be important in view of the fact that intra-
ocular neovascularization is often accompanied by
fibrous tissue proliferation (26) .
In conclusion, we have demonstrated, for the
first time, a retina-derived substance (or sub-
stances) capable of promoting vasoproliferation .
The mechanisms of production and release of this
vasoproliferative substance and the conditions that
promote its liberation by retina are being investi-
gated in our laboratory . Characterization and pu-
rification of this substance are also proceeding .
This vasoproliferative substance will play an im-
portant role in the investigation of intraocular
neovascularization and angiogenesis, in general,
and will aid in identifying substances capable of
inhibiting the neovascular response.
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